n(g),n(g')-dimethyl-l-arginine has been researched along with Shock, Cardiogenic in 2 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
Excerpt | Relevance | Reference |
---|---|---|
"Systemic inflammation and elevated circulating levels of the endogenous nitric oxide inhibitor asymmetrical dimethylarginine (ADMA) have been associated with increased risk in cardiogenic shock (CS)." | 3.77 | Inflammation and reduced endothelial function in the course of severe acute heart failure. ( Hermansen, SE; How, OJ; Kalstad, T; Myrmel, T, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hermansen, SE | 1 |
Kalstad, T | 1 |
How, OJ | 1 |
Myrmel, T | 1 |
Kielstein, JT | 1 |
Sydow, K | 1 |
Thum, T | 1 |
2 other studies available for n(g),n(g')-dimethyl-l-arginine and Shock, Cardiogenic
Article | Year |
---|---|
Inflammation and reduced endothelial function in the course of severe acute heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Endothelium, Vas | 2011 |
Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
Topics: Arginine; Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Myocardial Infarction; Nitric Oxide | 2007 |